Assuta

1 stories · following the connections

Business

CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel’s Assuta Medical Centers to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & Cannabinoids

By Nasdaq OMXJul 11, 2017, 1:00 PM UTC